Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
about
A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-AnalysisCIViC databaseNucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies.Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis.SNP set association analysis for genome-wide association studies.Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysisPredictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjectsDNA repair gene ERCC1 C118T polymorphism predicts sensitivity of recurrent esophageal cancer to radiochemotherapy in a Chinese population.Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.XRCC1 polymorphisms and lung cancer risk in Caucasian populations: a meta-analysis.Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.XRCC3 gene polymorphism is associated with survival in Japanese lung cancer patients.ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatinAssociation of CHEK2 polymorphisms with the efficacy of platinum-based chemotherapy for advanced non-small-cell lung cancer in Chinese never-smoking women.Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysisPharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine.Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
P2860
Q26750858-89C624F2-5E57-4874-BCD4-3C0D793EBE3FQ27612411-97E37D59-020A-448A-991D-E9C2E1CBE0BBQ33733507-1079579A-2C4C-4B1B-B566-948FF94559F4Q33912148-7ECBE21A-4CFE-47F9-8BD6-523D2113262FQ34712532-6BB2173D-54FD-413B-8008-909545FEA5FEQ34742602-DD86E103-BB46-43E7-A315-96E036C97916Q34934491-CB145B00-FC3B-4AE3-9AA0-63333457E9A1Q34973738-6AB3C908-9F48-4D57-9F03-EE6FD2D1621FQ35015020-CC692FE6-E993-41AD-A47D-547EFA375A9DQ35048754-EEA5579D-FABC-4DEB-A62E-8A8869BDD624Q35173399-4EEEDC58-37B4-4476-8173-127D58EC87B4Q36247880-E817D485-8EC4-4409-B69B-BC8C9DB6C496Q36301463-601D27E8-CFC0-40B2-ABA7-E2B7B04865CBQ36317385-31C29029-1CB3-4F08-9086-AE97AC076D91Q36375374-B27B3DB2-6A02-48A8-ADD5-58A92612C30DQ36538494-893C4A91-2E85-4E4B-991D-3D2E45A6FEA4Q36893674-98BDB3F3-6ABB-45C4-A009-A0430755C59AQ37329388-193E7044-64A0-449C-96DB-14CAEFDF4096Q37688309-CF6D88CE-C5B1-4B7D-B3C3-729C79F2B8AEQ38909984-A6F533CB-7BB7-4822-A020-AE3BD727DE10Q38953629-4F1B8F30-6FD7-4E4D-89D8-71A566341D99Q41117085-1EC27576-DB40-4B72-8635-ED66555CAC10Q44778801-4CA25DAD-CB37-4F00-80B2-6B2CEFEE9A40Q44876602-1CC41970-9CBA-4DD7-80E4-A86F94514464
P2860
Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@ast
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@en
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@nl
type
label
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@ast
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@en
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@nl
prefLabel
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@ast
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@en
Genetic polymorphism of XRCC1 ...... ted with gemcitabine/platinum.
@nl
P2093
P50
P1476
Genetic polymorphism of XRCC1 ...... ated with gemcitabine/platinum
@en
P2093
Gee-Chen Chang
Jin-Yuan Shih
Yu-Kai Cheng
Yuh-Min Chen
P304
P356
10.1097/JTO.0B013E31824FE98C
P577
2012-06-01T00:00:00Z